BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24676670)

  • 1. Astragaloside Ⅳ reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines.
    Wang PP; Xu DJ; Huang C; Wang WP; Xu WK
    Mol Med Rep; 2014 Jun; 9(6):2131-7. PubMed ID: 24676670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II.
    Huang C; Xu D; Xia Q; Wang P; Rong C; Su Y
    J Pharm Pharmacol; 2012 Dec; 64(12):1741-50. PubMed ID: 23146037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV downregulates the expression of MDR1 in Bel‑7402/FU human hepatic cancer cells by inhibiting the JNK/c‑Jun/AP‑1 signaling pathway.
    Wang PP; Luan JJ; Xu WK; Wang L; Xu DJ; Yang CY; Zhu YH; Wang YQ
    Mol Med Rep; 2017 Sep; 16(3):2761-2766. PubMed ID: 28713943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
    Gu W; Fang FF; Li B; Cheng BB; Ling CQ
    Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects and Mechanisms of Periplaneta americana Extract Reversal of Multi-Drug Resistance in BEL-7402/5-FU Cells.
    Yuan F; Liu J; Qiao T; Li T; Shen Q; Peng F
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27367657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
    He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
    Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
    Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
    Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Huang C; Ma T; Jiang L; Tang L; Shi T; Zhang S; Zhang L; Zhu P; Li J; Shen A
    Phytomedicine; 2018 Apr; 43():37-45. PubMed ID: 29747752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
    Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
    Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Astragalus polysaccharides on P-glycoprotein efflux pump function and protein expression in H22 hepatoma cells in vitro.
    Tian QE; De Li H; Yan M; Cai HL; Tan QY; Zhang WY
    BMC Complement Altern Med; 2012 Jul; 12():94. PubMed ID: 22784390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Shi Z; Jain S; Kim IW; Peng XX; Abraham I; Youssef DT; Fu LW; El Sayed K; Ambudkar SV; Chen ZS
    Cancer Sci; 2007 Sep; 98(9):1373-80. PubMed ID: 17640301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
    Shi LX; Ma R; Lu R; Xu Q; Zhu ZF; Wang L; Zhou CL; Li XL; Zhang HL; Yao Z
    Cancer Lett; 2008 Sep; 269(1):101-10. PubMed ID: 18538471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragali radix and its main bioactive compounds activate the Nrf2-mediated signaling pathway to induce P-glycoprotein and breast cancer resistance protein.
    Lou Y; Guo Z; Zhu Y; Zhang G; Wang Y; Qi X; Lu L; Liu Z; Wu J
    J Ethnopharmacol; 2019 Jan; 228():82-91. PubMed ID: 30243825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reversion of drug-resistant hepatocellular carcinoma cell line BEL-7402/FU by sorafenib].
    Wei L; Su N; Zheng DY; Cao MR; Li AM; Yan X; Lü CW; Luo RC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):344-7. PubMed ID: 19351508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice.
    Zhang W; Liu M; Yang L; Huang F; Lan Y; Li H; Wu H; Zhang B; Shi H; Wu X
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30717494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
    Lu F; Hou YQ; Song Y; Yuan ZJ
    Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside II sensitizes human hepatocellular carcinoma cells to 5-fluorouracil via suppression of autophagy.
    Wang M; Huang C; Su Y; Yang C; Xia Q; Xu DJ
    J Pharm Pharmacol; 2017 Jun; 69(6):743-752. PubMed ID: 28266023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.